Asserts that few critical issues in drug programming are being thoughtfully considered. Suggests that health educators and other professionals involved in drug program development must seriously consider program problems of goal selection, policy development, student rights and protection, clarification of drug-related terminology, and evaluation processes. (Author/NB)